Alkermes
ALKS
#3093
Rank
C$6.73 B
Marketcap
C$40.78
Share price
0.75%
Change (1 day)
-6.75%
Change (1 year)

Alkermes (ALKS) - Cash on Hand

Cash on Hand as of September 2025 : C$1.53 Billion

According to Alkermes's latest financial reports the company has C$1.53 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Alkermes - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$1.07 B5.14%
2023-12-31C$1.02 B24.26%
2022-12-31C$0.82 B20.8%
2021-12-31C$0.68 B-15.59%
2020-12-31C$0.80 B15.88%
2019-12-31C$0.69 B-4.89%
2018-12-31C$0.73 B34.79%
2017-12-31C$0.54 B-18.44%
2016-12-31C$0.66 B-9.93%
2015-12-31C$0.74 B1.28%
2014-12-31C$0.73 B
2013-03-31C$0.22 B18.38%
2012-03-31C$0.19 B-2.58%
2011-03-31C$0.19 B-31.19%
2010-03-31C$0.28 B-30.31%
2009-03-31C$0.40 B17.61%
2008-03-31C$0.34 B-14.94%
2007-03-31C$0.40 B16.09%
2006-03-31C$0.35 B42.63%
2005-03-31C$0.24 B30.63%
2004-03-31C$0.18 B-5.87%
2003-03-31C$0.19 B-17.75%
2002-03-31C$0.24 B-39.59%
2001-03-31C$0.40 B-18.05%
2000-03-31C$0.49 B99.12%
1999-03-31C$0.24 B-10.5%
1998-03-31C$0.27 B133.42%
1997-03-31C$0.11 B169.05%
1996-03-31C$43.86 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Acorda Therapeutics
ACOR
C$12.93 M-99.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$22.79 B 1,385.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$25.64 B 1,570.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$20.70 B 1,248.56%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$11.30 B 636.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$3.04 B 98.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$14.43 B 840.67%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
C$13.47 B 777.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland